+44 (0)1509 263171
Please use this identifier to cite or link to this item:
|Title: ||Scanning the horizon for high value-add manufacturing science: accelerating readiness for the next generation of disruptive, high value curative cell therapeutics|
|Authors: ||Hourd, Paul C.|
Williams, David J.
Induced pluripotent stem cells
|Issue Date: ||2018|
|Citation: ||HOURD, P.C. and WILLIAMS, D.J., 2018. Scanning the horizon for high value-add manufacturing science: accelerating readiness for the next generation of disruptive, high value curative cell therapeutics. Cytotherapy, In Press.|
|Abstract: ||Since the Regenerative Medicine sector entered the second phase of its development (RegenMed 2.0) more than a decade ago, there is increasing recognition that current technology innovation trajectories will drive the next translational phase towards the production of disruptive, high value curative cell and gene based regenerative medicines. In this short report, a long lens look within the pluripotent stem cell therapeutic space, both embryonic and induced, is used to gain early insights on where critical technology and manufacturing challenges may emerge. The report offers a future perspective on the development and innovation that will be needed within manufacturing science to add value in the production and commercialisation of the next generation of advanced cell therapies and precision medicines.|
|Description: ||This paper is closed access until 12 months after publication.|
|Sponsor: ||The work described in this article was supported by the UK Regenerative Medicine Platform as part of the work of the Pluripotent Stem Cell Platform (Award MR/L012537/1) focussed on horizon scanning with respect to manufacturing.|
|Version: ||Accepted for publication|
|Publisher Link: ||https://www.journals.elsevier.com/cytotherapy|
|Appears in Collections:||Closed Access (Mechanical, Electrical and Manufacturing Engineering)|
Files associated with this item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.